Rankings
▼
Calendar
NAGE FY 2018 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena
NAGE
Niagen Bioscience Inc
$393M
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$32M
+48.8% YoY
Gross Profit
$16M
50.9% margin
Operating Income
-$33M
-105.1% margin
Net Income
-$33M
-105.6% margin
EPS (Diluted)
$-0.61
Cash Flow
Operating Cash Flow
-$21M
Free Cash Flow
-$22M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$42M
Total Liabilities
$15M
Stockholders' Equity
$27M
Cash & Equivalents
$22M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$32M
$21M
+48.8%
Gross Profit
$16M
$10M
+53.2%
Operating Income
-$33M
-$16M
-102.6%
Net Income
-$33M
-$11M
-192.8%
← Q4 2017
All Quarters
Q1 2018 →